Liver Disease Treatments: The Global Market

Report Code: PHM057A

Publish Date: Jun 2009

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global market for liver disease treatments amounted to nearly $8.4 billion in 2007 and is expected to increase to $9.8 billion in 2014, for a compound annual growth rate (CAGR) of 3.0%
  • The treatment for hepatitis is the largest segment of the market, amounting to about $4.6 billion in the last three years, and is expected to reach $4.8 billion in 2014.
  • Sales of targeted therapies were comparatively less in 2008, but this market has the potential to grow faster mainly because of the increased incidence of hepatitis C in developing countries.

INTRODUCTION

STUDY OBJECTIVES 

BCC's goal in conducting this study is to provide an overview of the current and potential aspects of the global market for liver diseases treatments. The report determines the market size and market leaders, provides a market overview, and examines factors affecting the markets for drugs used to treat liver diseases. The markets have been defined by disease type and by drug type. 

The overview of types of liver diseases, their symptoms and their treatments is examined along with sales figures over the five-year period from 2009 to 2014. The report also gives the demand and use criteria of the drugs used to treat liver diseases, as well as an overview of drug-induced liver diseases. Companies manufacturing and selling the drug products in this category are profiled, and factors affecting markets for these products and how the markets are likely to change are analyzed. Revenues have been broken down by the type of diseases and by different regions. 
 
Our key objective is to present a comprehensive analysis of the current market and the future direction of the drugs used to treat liver diseases.
 
REASONS FOR DOING THIS STUDY
 
A large number of studies are currently ongoing regarding hepatitis and other liver diseases, which influenced BCC’s desire to study this market.
 
This study looks at almost all of the types of products used to treat liver diseases, The research and development of new products, and the changes in market behavior that justify focusing on this segment. Finally, this study discusses the usage of these products.
 
INTENDED AUDIENCE
 
The study contributes to understanding market growth and decline in the market for liver disease treatments, from the point of view of the manufacturer and user.  This study will be of interest largely to the chemical, pharmaceutical and biopharmaceutical industries, as well as clinics and hospitals.  
 
SCOPE OF THE STUDY
 
The scope of this study encompasses the market for liver disease treatments. BCC analyzes each market and its leaders, the different types of liver diseases, the different types of drug products to treat liver diseases, the regulatory environment, the regional market for liver diseases and the drug products used to treat them, and market projections and market share. Technological issues include latest trends and new developments.
  
METHODOLOGY
 
A combination of primary and secondary research methods were used in this study. A comprehensive search of literature was conducted.  The literature included technical newsletters and journals as well as many other sources. The data were collected through interviews and correspondence with various pharmaceutical/ biotechnical experts. Projections were based on estimates such as the current number of end users, potential end users, likely unit prices, rates of consumption, and market trends.
 
 INFORMATION SOURCES
 
BCC surveyed many companies to obtain data for this study. Included were manufacturers and the end users of the drugs used to treat liver diseases. We gathered industry data, spoke with officials from this industry, and consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were done. In addition, we compiled data from current financial and trade information and government sources.
 
ABOUT THE AUTHOR
 
Shalini Shahani Dewan holds a Masters Degree in pharmaceutical chemistry.  Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shahani was awarded a gold medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are: Reagents of Chromatography; Spectroscopy, an Enduring Market; Advanced Drug Delivery Systems; Orthopedic Drugs, Implants and Devices; Imaging Reagents; Contract Manufacturing, Research and Packaging; The Dynamic Media, Sera and Reagent Market in Biotechnology; Opportunities in Chiral Technology; Behavioral and Emotional Disorders in Children and Adolescents; Pharmaceutical Regulatory Industry,and many more.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Liver Disease Treatments: The Global Market157Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY3Free
Chapter- 3: OVERVIEW20Free
Chapter- 4: REGULATORY ISSUES4Free
Chapter- 5: PREVALENCE5Free
Chapter- 6: CLASSIFICATION OF THERAPIES BY DISEASE13Free
Chapter- 7: INDUSTRY STRUCTURE 19Free
Chapter- 8: DEMAND AND USE3Free
Chapter- 9: MARKET ANALYSIS17Free
Chapter- 10: DRUG-INDUCED LIVER DISEASE6Free
Chapter- 11: NEW DEVELOPMENTS6Free
Chapter- 12: MARKET BY DRUG TYPE29Free
Chapter- 13: PATENT ANALYSIS8Free
Chapter- 14: C. CRAMER & CO. GMBH19Free
Chapter- 15: APPENDIX2Free

Related Reports

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 86

  • Summary Table: GLOBAL SALES OF LIVER DISEASE TREATMENTS, THROUGH 2014
  • Table 1: TYPES OF LIVER DISEASES
  • Table 2: APPROVED DRUGS USED TO TREAT LIVER DISEASES, 2005-2008
  • Table 3: NUMBER OF NEW APPROVALS FOR DRUGS USED TO TREAT LIVER DISEASES, 2005-2008
  • Table 4: NEW DRUG APPLICATIONS FOR DRUGS USED TO TREAT LIVER DISEASES, 2005-2008
  • Table 5: RECALLS OF DRUGS USED TO TREAT LIVER DISEASES, 2005-2008
  • Table 6: HEPATITIS BURDEN IN THE UNITED STATES (2005-2006)
  • Table 7: INCIDENCE OF ACUTE HEPATITIS BY SEX AND AGE IN THE UNITED STATES (2006)
  • Table 8: VACCINES FOR HEPATITIS A PREVENTION
  • Table 9: VACCINES FOR HEPATITIS B PREVENTION
  • Table 10: NUCLEOSIDE ANALOGS USED TO TREAT HEPATITIS
Sample Report

Recent Reports

Clinical Nutrition: Global Markets to 2031

Published - Jun 2026 | Publisher - BCC Publishing | Code - PHM198C

The global market for clinical nutrition is expected to grow from $79.5 billion in 2026 and is projected to reach $104.7 billion by the end of 2031, at a compound annual growth rate (CAGR) of 5.6% during the forecast period of 2026 to 2031.

Substance Use Disorder Treatment: Global Markets to 2030

Published - Jun 2026 | Publisher - BCC Publishing | Code - PHM035D

The global substance use disorder (SUD) treatment market was valued at $11.6 billion in 2025, and it is expected to reach $14.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2030.

In Vitro Toxicity Testing: Technologies and Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - PHM017H

The global in vitro toxicity testing market was valued at $17.4 billion in 2025 and is projected to reach $28 billion by the end of 2030, at a compound annual growth rate of 10% from 2025 to 2030.

Cardiovascular Drugs: Global Markets to 2030

Published - Apr 2026 | Publisher - BCC Publishing | Code - PHM191B

The global market for cardiovascular drugs was valued at $183.7 billion in 2025 and is estimated to reach $228.6 billion by 2030, at a compound annual growth rate (CAGR) of 4.5% from 2025 through 2030.

Emerging Drugs: Global Markets

Published - Apr 2026 | Publisher - BCC Publishing | Code - PHM291A

The report provides an overview of the global emerging drugs and analyzes market trends, segmented by molecule type, product type, therapeutic application, and end user. It includes global revenue for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The report focuses on trends, challenges, and the competitive landscape, including market share of leading companies and company profiles with financials, product portfolios, and recent developments.

Top Trending Reports

2025 Medical Devices Research Review

Published - Apr 2026 | Publisher - BCC Publishing | Code - MDS060C

Get a concise view of the medical devices sector with BCC Research’s 2025 review covering market dynamics, emerging technologies and industry developments.

Cancer Profiling and Pathways: Technologies and Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - BIO073D

The global market for cancer profiling and pathway technologies is expected to grow from $18.3 billion in 2025 and is projected to reach $33.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.2% during the forecast period of 2025 to 2030.

Validation, Calibration, and Standardization in the Life Sciences Market

Published - Mar 2026 | Publisher - BCC Publishing | Code - BIO179B

The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.

Glass Fiber: Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - AVM225B

The global market for glass fiber is expected to grow from $13.5 billion in 2026 and is projected to reach $17.2 billion by the end of 2031, at a compound annual growth rate (CAGR) of 4.9% during the forecast period of 2026 to 2031.

2025 Chemical Research Review

Published - Apr 2026 | Publisher - BCC Publishing | Code - CHM190B

BCC Research’s 2025 Chemical Research Review covering market trends, specialty chemicals, industrial innovation and growth opportunities across the chemical industry.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Liver Disease Treatments: The Global Market
Customize Report
AI Sentiment